Categories
Latest Market Reports Market Study

Global Liraglutide Injection Market Is Expected to Grow At a CAGR of 13.7% From 2020 to 2027

Liraglutide injection first received its approval from the FDA in January 2010 for the management of type 2 diabetes, and is currently the sole property of Novo Nordisk A/S and is commercially available as Saxenda, Victoza, and Xultophy across the globe.

Type 2 diabetes is representing the largest market share in the clinical application for the liraglutide injection market. According to the latest statistics provided by the International Diabetes Federation (IDF), it is estimated that 79% of the adult population suffering from type 2 diabetes are living in the middle and low-income countries, the further clinical investigation has reported that by 2045 the number of people suffering from type 2 diabetes globally will reach to 700 million. Obesity is keen to register impressive market growth during the forecast period on account of the increasing consumption of junk food, alcohol, tobacco, and sedentary lifestyle among the young adult population worldwide. As per the latest information provided by the World Health Organization (WHO), in 2019 approximately 38.2 million children under the age of 5 years were reported as overweight.

Browse the full report Liraglutide Injection Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/liraglutide-injection-market

Hospital pharmacy is presently dominating the distribution channel segment in the liraglutide injection market. The occurrence of thyroid cancer in patients due to repeated injudicious exposure of liraglutide injection makes it necessary for accurate drug compounding in the presence of a hospital pharmacist to prevent such fatal health outcomes. It is expected that in the near future retail pharmacy will be showcasing exemplary market growth in the developing regions of the world owing to the provision of cheap medicines due to the imposition of government subsidy for essential medicines.

North America is currently leading the geography segment for the liraglutide injection market. Rising prevalence of type 2 diabetes primarily drives the liraglutide market growth in the region. As per the latest research citings presented by the American Diabetes Association (ADA), approximately 29.1 million people in the United States are suffering from type 2 diabetes. Additionally, an affordable reimbursement scenario regarding the use of liraglutide injection in the management of type 2 diabetes and obesity further accentuates the market growth. Europe is considered as the second-largest regional segment in the liraglutide injection market. The nurturing regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of liraglutide injection will further propel the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment in the liraglutide market on account of the developing healthcare infrastructure and rising public health awareness regarding the therapeutic efficacy of liraglutide in the management of type 2 diabetes and obesity prevalence in the Asia Pacific region.

Key Market Movements:

  • Rising prevalence of type 2 diabetes worldwide
  • Significant increase in the number of young adults suffering from obesity across the globe
  • Affordable reimbursement scenario regarding the use of liraglutide injection for the management of type 2 diabetes and obesity

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Latest Market Reports Market Study

Global Flexible Spinal Implants Market Is Expected to Grow At a CAGR of 13.1% From 2020 to 2027

Flexible spinal implants are being widely employed by surgeons across the globe owing to its ability to correct deformities, strengthening and improving the flexibility and stability of spine movement, etc.

In the present scenario, cervical are reigning the clinical applications segment for the flexible spinal implants market. Rising prevalence of cervical disc herniation due to severe spinal injury associated with traumatic accidents primarily drives the market growth. According to the latest statistics presented by the International Osteoporosis Foundation (IOF), it is estimated that approximately after every 3 seconds an osteoporotic fracture is reported throughout the globe, additionally, it is further recorded that 75% of the spine and hip fracture occurs in the elderly population aged 65 years and above. Lumbar will be registering comfortable market growth during the forecast period on account of the significant increase in the number of young athletes suffering from mid and lower back trauma occurring due to physical and sports activities related to gymnasium and weightlifting throughout the globe.

Browse the full report Flexible Spinal Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/flexible-spinal-implants-market

Hospitals & clinics are presently leading the end-user segment for the flexible spinal implants market. The constant rise in the number of inpatients accidents in the emergency units of hospitals due to traumatic injuries inflicted on victims due to occupational hazards in the developing regions and car accidents in the developed region determines the market growth. Ambulatory surgical centers are expected to register excellent market growth in the near future on account of the proactive government initiatives adopted by the government healthcare agencies to promote ambulatory surgical centers to reduce the healthcare cost and burden associated with inpatients treatment in primary health care centers across the globe.

North America is currently dominating the geography segment for the flexible spinal implants market. The growing incidence of osteoporotic spinal degeneration in the elderly population primarily drives the flexible spinal implants market growth in the region. Affordable reimbursement scenario and existence of key players such as Stryker Corporation, Medtronic, Plc., Abbott Spine, Inc., etc. further consolidates the market growth in the region. Europe is placed in the 2nd position in the regional segment on account of the growing incidence of traumatic accidents due to vehicle collisions in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the flexible spinal implants market. Significant rise in the number of spinal injuries associated with sports activities such as gymnastics and weightlifting and increasing demand for minimally invasive surgical spinal procedures together propel the market growth in the Asia Pacific region.

Medical device manufacturers actively engaged in the production of flexible spinal implants are Medtronic, Plc., Abbott Spine, Inc., RTI Surgical, Zimmer Biomet Holdings, Inc., Stryker Corporation, B. Braun Melsungen AG., Orthofix International N.V., NuVasive, Inc., Paradigm Spine, LLC., and Alphatec Holdings, Inc.

Key Market Movements:

  • Rising prevalence of osteoporosis among the elderly population worldwide
  • Technological advancement in the flexible spine implants and increasing public health awareness regarding its benefit in restoring spinal flexibility accentuates the market growth
  • Increasing demand for minimally invasive surgical procedures further propels the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports

Global Endocrinology Hormone Reagents Market Is Expected To Grow At A CAGR of 8.1% From 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global population will be suffering with non-communicable diseases. Increasing funds are being provided by the governmental healthcare agencies in the research and development segment of life science industry for novel drug development in order to curb the mortality rate associated with chronic diseases worldwide.

North America is spearheading the segment for the Endocrinology Hormone Reagents Market. Rising prevalence of chronic lifestyle diseases throughout the globe primarily drives the market growth. It is considered as the first line therapy for the treatment of chronic lifestyle diseases owing to its excellent therapeutic efficacy and safety with minimal effects. Europe is anticipated to register rampant market growth in the near future on account of its increasing demand as a treatment option for patients non-responsive to the first line therapy.

Browse the full report Endocrinology Hormone Reagents Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/endocrinology-hormone-reagents-market

Hospital pharmacy is presently leading the distribution channel segment for Endocrinology Hormone Reagents Market. It is noteworthy to understand the medicines prescribed for the treatment of Endocrinology Hormone Reagents Market needs to be accurately dispensed by the hospital pharmacist to avoid occurrence of any drug related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater the medical requirement of people residing in the remote locations.

North America is currently spearheading the geography segment for the Endocrinology Hormone Reagents Market. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario together drive the market growth in the region. Europe is in the 2nd place in the regional segment for the Endocrinology Hormone Reagents Market. Supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of Endocrinology Hormone Reagents Market together accentuate the market growth in the region. Additionally, the strategic collaboration between the pharmaceutical companies and academic research institutes for the development of Endocrinology Hormone Reagents Market further propel the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment Endocrinology Hormone Reagents Market during the forecast period.  Developing healthcare infrastructure and flourishing generic drugs market determine the market growth of Endocrinology Hormone Reagents Market in the Asia Pacific region. It provides lucrative market opportunites for the western giants to establish retail outlets and subsidiaries.

Pharmaceutical manufacturers actively engaged in the production of Endocrinology Hormone Reagents Market drugs are Abbott Laboratories, Inc., Agilent Technologies, Inc., Quest Diagnostics, bioMerieux SA., Bio Rad Laboratories, Inc., LabCorp., DiaSorin (American Standard Companies), Meridian Life Science, Inc., Thermo Fisher Scientific, Roche Diagnostics.

Key Market Movements:

  • Rising prevalence of Endocrinology Hormone Reagents Market throughout the globe
  • Supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of Endocrinology Hormone Reagents Market
  • Affordable reimbursement scenario for the drugs employed for the treatment of Endocrinology Hormone Reagents Market will further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports

Global Probiotic Dietary Supplements Market Is Expected to Grow At A CAGR of 7.5% from 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global population will be suffering with non-communicable diseases. Increasing funds are being provided by the governmental healthcare agencies in the research and development segment of life science industry for novel drug development in order to curb the mortality rate associated with chronic diseases worldwide.

Europe is spearheading the segment for the Probiotic Dietary Supplements Market. Rising prevalence of public health awareness throughout the globe primarily drives the market growth. It is considered as the first line therapy for the treatment of public health awareness owing to its excellent therapeutic efficacy and safety with minimal effects. Asia Pacific is anticipated to register rampant market growth in the near future on account of its increasing demand as a treatment option for patients non-responsive to the first line therapy.

Browse the full report Probiotic Dietary Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/probiotic-dietary-supplements-market

Hospital pharmacy is presently leading the distribution channel segment for Probiotic Dietary Supplements Market. It is noteworthy to understand the medicines prescribed for the treatment of Probiotic Dietary Supplements Market needs to be accurately dispensed by the hospital pharmacist to avoid occurrence of any drug related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater the medical requirement of people residing in the remote locations.

Europe is currently spearheading the geography segment for the Probiotic Dietary Supplements Market. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario together drive the market growth in the region. Asia Pacific is in the 2nd place in the regional segment for the Probiotic Dietary Supplements Market. Supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of Probiotic Dietary Supplements Market together accentuate the market growth in the region. Additionally, the strategic collaboration between the pharmaceutical companies and academic research institutes for the development of Probiotic Dietary Supplements Market further propel the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment Probiotic Dietary Supplements Market during the forecast period.  Developing healthcare infrastructure and flourishing generic drugs market determine the market growth of Probiotic Dietary Supplements Market in the Asia Pacific region. It provides lucrative market opportunites for the western giants to establish retail outlets and subsidiaries.

Pharmaceutical manufacturers actively engaged in the production of Probiotic Dietary Supplements Market drugs are NutraScience Labs, Vitakem Nutraceuticals, Inc., ProbioFerm, Probium LLC., Protexin (Archer Daniels Midland), Nutraceutix (Probi), Mercola Probiotics, Unison Laboratories Co Ltd., Custom Probiotics, Inc., Chr. Hansen Holding A/S.

Key Market Movements:

  • Rising prevalence of Probiotic Dietary Supplements Market throughout the globe
  • Supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of Probiotic Dietary Supplements Market
  • Affordable reimbursement scenario for the drugs employed for the treatment of Probiotic Dietary Supplements Market will further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson

Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports Market Study

Global Propranolol Hydrochloride Market Is Expected to Grow At A CAGR Of 2.6% from 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global population will be suffering with non-communicable diseases. Increasing funds are being provided by the governmental healthcare agencies in the research and development segment of life science industry for novel drug development in order to curb the mortality rate associated with chronic diseases worldwide.

North America is spearheading the segment for the Propranolol Hydrochloride Market. Rising prevalence of cardiac complications throughout the globe primarily drives the market growth. It is considered as the first line therapy for the treatment of cardiac complications owing to its excellent therapeutic efficacy and safety with minimal effects. Europe is anticipated to register rampant market growth in the near future on account of its increasing demand as a treatment option for patients non-responsive to the first line therapy.

Browse the full report Propranolol Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/propranolol-hydrochloride-market

Hospital pharmacy is presently leading the distribution channel segment for Propranolol Hydrochloride Market. It is noteworthy to understand the medicines prescribed for the treatment of Propranolol Hydrochloride Market needs to be accurately dispensed by the hospital pharmacist to avoid occurrence of any drug related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater the medical requirement of people residing in the remote locations.

North America is currently spearheading the geography segment for the Propranolol Hydrochloride Market. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario together drive the market growth in the region. Europe is in the 2nd place in the regional segment for the Propranolol Hydrochloride Market. Supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of Propranolol Hydrochloride Market together accentuate the market growth in the region. Additionally, the strategic collaboration between the pharmaceutical companies and academic research institutes for the development of Propranolol Hydrochloride Market further propel the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment Propranolol Hydrochloride Market during the forecast period.  Developing healthcare infrastructure and flourishing generic drugs market determine the market growth of Propranolol Hydrochloride Market in the Asia Pacific region. It provides lucrative market opportunites for the western giants to establish retail outlets and subsidiaries.

Pharmaceutical manufacturers actively engaged in the production of Propranolol Hydrochloride Market drugs are Mylan Pharmaceutical Industries Limited, Lupin Pharma, AstraZeneca, Plc., Teva Pharmaceutical Industries Limited, Accord Healthcare, Aurobindo Pharma, Sandoz, Inc., Pierre Fabre, Helvepharm AG, Apotex Corporation.

Key Market Movements:

  • Rising prevalence of Propranolol Hydrochloride Market throughout the globe
  • Supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of Propranolol Hydrochloride Market
  • Affordable reimbursement scenario for the drugs employed for the treatment of Propranolol Hydrochloride Market will further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports

Global Silymarin Market Is Expected to Grow At A CAGR of 7.5% from 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global population will be suffering with non-communicable diseases. Increasing funds are being provided by the governmental healthcare agencies in the research and development segment of life science industry for novel drug development in order to curb the mortality rate associated with chronic diseases worldwide.

North America is spearheading the segment for the Silymarin Market. Rising prevalence of hepatic diseases throughout the globe primarily drives the market growth. It is considered as the first line therapy for the treatment of hepatic diseases owing to its excellent therapeutic efficacy and safety with minimal effects. Europe is anticipated to register rampant market growth in the near future on account of its increasing demand as a treatment option for patients non-responsive to the first line therapy.

Browse the full report Silymarin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/silymarin-market

Hospital pharmacy is presently leading the distribution channel segment for Silymarin Market. It is noteworthy to understand the medicines prescribed for the treatment of Silymarin Market needs to be accurately dispensed by the hospital pharmacist to avoid occurrence of any drug related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater the medical requirement of people residing in the remote locations.

North America is currently spearheading the geography segment for the Silymarin Market. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario together drive the market growth in the region. Europe is in the 2nd place in the regional segment for the Silymarin Market. Supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of Silymarin Market together accentuate the market growth in the region. Additionally, the strategic collaboration between the pharmaceutical companies and academic research institutes for the development of Silymarin Market further propel the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment Silymarin Market during the forecast period.  Developing healthcare infrastructure and flourishing generic drugs market determine the market growth of Silymarin Market in the Asia Pacific region. It provides lucrative market opportunites for the western giants to establish retail outlets and subsidiaries.

Pharmaceutical manufacturers actively engaged in the production of Silymarin Market drugs are LIVERD PHARMA, Jiaherb, Panjin Fengrui, Huacheng Pharmaceutical, TY Pharmaceutical, Shengbo Silymarin, Swanson Health Products, Jarrow Formula, Sundown Naturals., Nature’s Bounty, Co.

Key Market Movements:

  • Rising prevalence of Silymarin Market throughout the globe
  • Supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of Silymarin Market
  • Affordable reimbursement scenario for the drugs employed for the treatment of Silymarin Market will further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports Market Study

Global Berberine Market Is Expected To Grow At A CAGR Of 9.2% From 2020 To 2027

Berberine is a naturally occurring alkaloid currently being employed in the treatment of metabolic-related disorders. The known mechanism of action as observes by scientist throughout the globe is the activation of AMP-activated protein kinase (AMPK) an enzyme which is responsible for regulating the production and use of energy in the human body.

Metabolic syndrome is spearheading the clinical application segment for the berberine extracts market. According to the latest statistics provided by the World Health Organization (WHO), approximately 1.9 billion adult populations worldwide are suffering from obesity which is a precursor for the occurrence of early onset of type 2 diabetes and high blood cholesterol levels causing cardiovascular complications in later stages of life. In the near future inflammation will register rampant market growth on account of the growing incidence of viral infection throughout the globe and increasing public health awareness regarding the benefits of berberine extract as an immunity booster.

Browse the full report Berberine Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/berberine-market

The supermarket is currently leading the distribution channel segment for the berberine market. The majority of the consumers living in metropolitan cities opt for a one-stop shopping destination to fulfill their shopping experience of branded herbal nutrition products, which are exhibited in supermarkets throughout the globe. Dieticians and nutrition experts recommend berberine products to consumers who prefer purchasing herbal products from local retail stores. E-commerce is expected to highlight outstanding market performance during the forecast period chiefly due to deep internet penetration and access to smart mobiles throughout the globe assisting people to avail E-commerce facility for purchasing quality herbal products at affordable prices and attractive discounts.

North America is representing the largest market share in the geography segment for the berberine market. The growing incidence of type 2 diabetes in young adults primarily drives the market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 1 in 10 Americans are suffering from type 2 diabetes in the region. Additionally, the domicile of key players such as Swanson Health Products, Piping Rock Health Products, Thorne Research, Inc., etc. further consolidates the market growth in the region. Europe is placed 2nd in the regional segment on account of the rising public health awareness regarding the therapeutic potential exhibited by berberine extracts in the treatment of infection associated inflammation in the region, additionally, poor lifestyle and stress are associated with the surge in metabolic syndrome in a young adult patient. The Asia Pacific is anticipated to be the fastest-growing regional segment for the berberine market. The presence of a well-established traditional herbal products market and the growing incidence of cancer together increase the demand for the berberine market in the Asia Pacific region.

Nutraceutical manufacturers actively engaged in the production of berberine are Piping Rock Health Products, Swanson Health Products, Thorne Research, Inc., Dr. Whitaker, Sunergetic, Himalaya Herbal Healthcare., Enzymedica., Solaray, Inc. (Nutraceutical International Corporation), Hangzhou Gosun Biotech Co., Ltd., and HerbaKraft, Inc.

Key Market Movements:

  • Rising incidence of diabetes and obesity among the young adult population worldwide
  • Increasing public health awareness regarding the clinical application of berberine extract in the treatment of inflammation associated with infectious diseases
  • Nurturing regulatory environment provided by the healthcare agencies worldwide for berberine extracts health supplements

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports Market Study

Global Warfarin Market Is Expected To Grow At A CAGR of 2.3% from 2020 to 2027

Warfarin is classified as an anticoagulant which is used to prevent the formation of blood clot and migraine. It is a vitamin K antagonist that inhibits its production by the vitamin K epoxide reductase.

Atrial fibrillation is representing the largest market share in the clinical application segment for the warfarin market. As per the latest information provided by the National Institute of Health (NIH), the global prevalence rate of atrial fibrillation has increased by 33% over the last 2 years. DVT/PE will be highlighting comfortable market growth in the near future on account of the growing prevalence rate in the elderly population worldwide. According to the recent information provided by the International Society on Thrombosis and Haemostasis (ISTH), annually 10 million new cases are reported worldwide to be suffering from venous thromboembolism. The clinical manifestations associated with venous thromboembolism are shortness of breath, chest pain swelling of foot and ankles, pain and tenderness in the calf region, lightheadedness, etc.

Browse the full report Warfarin Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/warfarin-market

Hospital pharmacy is currently leading the distribution channel segment for the warfarin market. Severe adverse events associated with warfarin such as throbbing headache, coughing of blood, joint pain makes it imperative for the accurate compounding of warfarin in the presence of a hospital pharmacist. Retail pharmacy is expected to garner impressive market performance during the forecast period owing to the availability of affordable essential medicines due to government subsidy and its capacity to provide medicinal requirements to households residing in remote locations.

North America is presently dominating the regional segment for the warfarin market. The growing incidence of cardiac diseases primarily drives the warfarin market growth in the region. According to the latest information provided by the Center for Disease Control and Prevention (CDC), the prevalence rate of DVT/PE is 1 to 2 per 1000 individuals annually in the United States. Domicile of key players such as Bristol-Myers Squibb Company, Apotex Corporation, Upsher-Smith Laboratories, LLC. etc. further consolidates the market growth in the region. Europe is placed 2nd in the regional segment for the warfarin market on account of the growing incidence of atrial fibrillation across all age groups in the region. Furthermore, the affordable reimbursement scenario associated with the medicinal use of warfarin determines the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the warfarin market owing to the effective implementation of treatment guidelines regarding cardiovascular diseases by the local healthcare agencies and the flourishing generic drugs market.

Pharmaceutical manufacturers actively engaged in the production of warfarin are Bristol-Myers Squibb Company, Apotex Corporation, Upsher-Smith Laboratories, LLC., Zydus Healthcare., Cipla Limited., Orion Pharma., Teva Pharmaceutical Industries Limited., Mylan Pharmaceutical Industries Limited., Taro Pharmaceutical Industries Ltd and IPCA Labs Ltd.

Key Market Movements:

  • Rising prevalence of atrial fibrillation worldwide
  • Significant increase in the number of individuals suffering with deep vein thrombosis across the globe
  • Affordable reimbursement scenario for the medicinal use of warfarin products further proles the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports Market Study

Global Propolis Market Is Expected To Grow At A CAGR of 2.2% from 2020 to 2027

Propolis is a heterogeneous mixture of naturally occurring resins and beeswax which is collected by the honeybees from various plants which serves to protect and sterilize the beehive which serves as a natural immune defense system for the whole beehive. The major drawback associated with this market is the lack of regulatory norms and compliance standards that have resulted in the sale of counterfeit products in the market as propolis containing products.

Cosmetic and personal care products are dominating the application segment for the propolis market. According to the latest statistics presented by the World Health Organization (WHO), traumatic burns represent 1% of the global burden of diseases which concomitantly increases the traction for propolis products for its treatment. Healthcare is going to record exemplary market performance during the forecast period on account of the therapeutic efficacy demonstrated by propolis in the treatment of gastrointestinal ulcers. The clinical trial investigation has confirmed the clinical application of propolis as a potent antitumor agent due to the presence of caffeic acid and its derivatives in the natural propolis.

Browse the full report Propolis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/propolis-market

Extracts are reigning the product type segment for the propolis market. According to the latest information provided by the World Health Organization (WHO), it is estimated that 1 to 2% of the global population suffers from some form of skin wound infection during their lifetime, which subsequently increases the demand for the propolis market. Propolis spray is expected to register excellent market growth in the near future owing to its increasing application for the treatment of sore throat due to the antibacterial and anti-inflammatory properties exhibited by natural propolis.

North America is currently leading the geography segment for the propolis market. The growing incidence of dermatology complications drives market growth in the region. Flourishing pharmaceutical segment further accentuates the propolis market growth owing to its ability to treat gastrointestinal ulcers. As per the latest research citings provided by the National Institute of Health (NIH) approximately 95% of the United States population suffer from acne during their adolescent lifetime which increases the demand for propolis extract in the region. Europe is placed 2nd in the regional segment owing to the flourishing cosmetic and personal care industrial segment in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the propolis market. The existence of traditional medicines in South Asian countries primarily determines the propolis market growth in the region. The constant rise in e-commerce as a distribution channel further accentuates the market growth in the Asia Pacific region.

Natural product manufacturers actively engaged in the production of propolis are Apis Flora, Comvita, Sunyata Pon Lee, Laprell’s Beehive Products, Inc., Apiário Polenectar, Hi-Tech Natural Product India Ltd., Manuka Health New Zealand, Wax Green, Bee Health Limited and Uniflora.

Key Market Movements:

  • Rising prevalence of skin complications worldwide
  • Increasing public health awareness regarding the therapeutic efficacy of propolis in the treatment of inflammatory response associated with a bacterial or viral infection
  • Flourishing traditional medicine market in the South Asian countries to further accentuate the propolis market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Health Latest Market Reports

Global Lipid Lowering Drugs Market Is Expected to Grow At A CAGR of 2.6% From 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global population will be suffering with non-communicable diseases. Increasing funds are being provided by the governmental healthcare agencies in the research and development segment of life science industry for novel drug development in order to curb the mortality rate associated with chronic diseases worldwide.

North America is spearheading the segment for the Lipid Lowering Drugs Market. Rising prevalence of hyperlipidemia throughout the globe primarily drives the market growth. It is considered as the first line therapy for the treatment of hyperlipidemia owing to its excellent therapeutic efficacy and safety with minimal effects. Europe is anticipated to register rampant market growth in the near future on account of its increasing demand as a treatment option for patients non-responsive to the first line therapy.

Browse the full report Lipid Lowering Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/lipid-lowering-drugs-market

Hospital pharmacy is presently leading the distribution channel segment for Lipid Lowering Drugs Market. It is noteworthy to understand the medicines prescribed for the treatment of Lipid Lowering Drugs Market needs to be accurately dispensed by the hospital pharmacist to avoid occurrence of any drug related adverse events. Retail pharmacy is gaining tremendous demand as a sales channel in the developing regions on account of established generic drugs market and the ability to cater the medical requirement of people residing in the remote locations.

North America is currently spearheading the geography segment for the Lipid Lowering Drugs Market. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario together drive the market growth in the region. Europe is in the 2nd place in the regional segment for the Lipid Lowering Drugs Market. Supportive regulatory environment provided by the European Medical Agency (EMA), for the sale and distribution of Lipid Lowering Drugs Market together accentuate the market growth in the region. Additionally, the strategic collaboration between the pharmaceutical companies and academic research institutes for the development of Lipid Lowering Drugs Market further propel the market growth in the region. Asia Pacific is anticipated to be the fastest-growing segment Lipid Lowering Drugs Market during the forecast period.  Developing healthcare infrastructure and flourishing generic drugs market determine the market growth of Lipid Lowering Drugs Market in the Asia Pacific region. It provides lucrative market opportunites for the western giants to establish retail outlets and subsidiaries.

Pharmaceutical manufacturers actively engaged in the production of Lipid Lowering Drugs Market drugs are AstraZeneca, Plc., Merck Co., Inc., Pfizer, Inc., Amgen, Inc., Sanofi, AbbVie, Inc., Novartis AG., Bristol-Myers Squibb & Company, Lupin Pharmaceuticals, Inc., Aralez Pharmaceuticals, Inc.

Key Market Movements:

  • Rising prevalence of Lipid Lowering Drugs Market throughout the globe
  • Supportive regulatory environment provided by the global healthcare agencies for the sale and distribution of Lipid Lowering Drugs Market
  • Affordable reimbursement scenario for the drugs employed for the treatment of Lipid Lowering Drugs Market will further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]